Table 5 Reasons for not receiving GDT (n = 106)
Reason | Frequency (%) |
|---|---|
No actionable mutations | 11 (10%) |
Disease in remission/no indication for therapy | 18 (17%) |
Patient still receiving standard of care/off-label option or clinical trial not suggested by F1 report | 42 (40%) |
Patient is no longer a candidate for therapy due to deteriorating or poor performance status | 25 (23%) |
Physician preference for no GDT specifically because of rapid disease | 5 (5%) |
On/off label GDT recommended or clinical trial available locally but patient declined | 3 (3%) |
Patient offered clinical trial but unable to travel/insurance decline | 2 (2%) |